Literature DB >> 18846322

IgM multiple myeloma: a diagnostic challenge in a patient with coexisting chronic lymphocytic leukaemia.

Saman Hewamana1, Chris Pepper2, Steve Couzens3, Alun Thomas3, Steven Knapper2.   

Abstract

As IgM multiple myeloma is a rare poorly characterised disease entity; there is only limited published data on its clinical, microscopic and immunophenotypic features. We report a 72-year-old man misdiagnosed as Waldenström's macroglobulinemia. Also the diagnosis was further complicated by coexisting chronic lymphocytic leukaemia. Following confirmation of IgM myeloma, in view of the patient's deteriorating clinical condition; he was entered into the UK Medical Research Council Myeloma IX trial where he had partial response to chemotherapy. This case highlights the value of detailed immunophenotypic evaluation when clinical and morphological markers are equivocal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18846322     DOI: 10.1007/s12185-008-0179-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  9 in total

1.  IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality.

Authors:  A Chehal; A Taher; A Shamseddine
Journal:  Clin Lab Haematol       Date:  2003-06

2.  IgM multiple myeloma: report of four cases and review of the literature.

Authors:  Ombretta Annibali; Maria Teresa Petrucci; Patrizia Del Bianco; Cristiano Gallucci; Anna Levi; Robin Foà; Giuseppe Avvisati
Journal:  Leuk Lymphoma       Date:  2006-08

3.  IgM myeloma--its distinction from Waldenström's macroglobulinemia.

Authors:  K Takahashi; F Yamamura; H Motoyama
Journal:  Acta Pathol Jpn       Date:  1986-10

Review 4.  [IgM myeloma: 6 cases and a review of the literature].

Authors:  A De Gramont; B Grosbois; J L Michaux; A M Peny; J P Pollet; N Smadja; M Krulik; J Debray; J F Bernard; M Monconduit
Journal:  Rev Med Interne       Date:  1990 Jan-Feb       Impact factor: 0.728

Review 5.  The spectrum of IgM monoclonal gammopathy in 430 cases.

Authors:  R A Kyle; J P Garton
Journal:  Mayo Clin Proc       Date:  1987-08       Impact factor: 7.616

6.  Clinicopathological correlates of IgM paraproteinemias.

Authors:  R G Owen; L A Parapia; J Higginson; S A Misbah; J A Child; G J Morgan; A S Jack
Journal:  Clin Lymphoma       Date:  2000-06

7.  Waldenström macroglobulinemia: MR imaging of the spine and CT of the abdomen and pelvis.

Authors:  L A Moulopoulos; M A Dimopoulos; D G Varma; J T Manning; D A Johnston; N E Leeds; H I Libshitz
Journal:  Radiology       Date:  1993-09       Impact factor: 11.105

Review 8.  The incidence and epidemiology of plasma cell neoplasms.

Authors:  D Bergsagel
Journal:  Stem Cells       Date:  1995-08       Impact factor: 6.277

9.  IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia.

Authors:  M H Zarrabi; R S Stark; P Kane; C L Dannaher; S Chandor
Journal:  Am J Clin Pathol       Date:  1981-01       Impact factor: 2.493

  9 in total
  1 in total

1.  IgM multiple myeloma presenting with bleeding tendency: a case report with immunophenotype analysis.

Authors:  Ling Zheng; Zhiyong Zeng; Junfang Lin; Junmin Chen
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.